CardioMEMS has raised $37.9 million to complete its CHAMPION clinical trial that will evaluate the safety of its heart failure (HF) pressure measurement system.
According to Atlanta-based CardioMEMS, the CHAMPION trial will evaluate 550 HF patients at 65 clinical trial sites across the U.S., and will be led by Philip Adamson, MD, director of the Oklahoma Heart Institute in Tulsa, Okla.
The company said that its wireless HF sensor is implanted into the pulmonary artery during a catheter-based procedure where pulmonary artery pressure is then measured by the CardioMEMS electronic monitoring system.
CardioMEMS said that patient information is taken at home and transmitted directly to a physician database.
Patient enrollment of the CHAMPION trial took place in 2009 and CardioMEMS said it expects results of the CHAMPION trial to be released in summer 2010.